Antipsychotic Efficacy, Safety of ALKS 3831 Evaluated in Acute Schizophrenia - Psychiatry Advisor

Submitted by Anonymous (not verified) on Sun, 05/06/2018 - 13:04

Psychiatry AdvisorAntipsychotic Efficacy, Safety of ALKS 3831 Evaluated in Acute SchizophreniaPsychiatry AdvisorNEW YORK — ALKS 3831, a treatment for schizophrenia composed of a flexible dose of olanzapine and a fixed dose of 10 mg samidorphan, demonstrated greater antipsychotic efficacy compared with placebo and a safety profile similar to that of olanzapine ...